Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Medical Properties Trust
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
International Healthcare Markets Will Benefit From Demographic Trends
Key Takeaways Growing rental income and stronger operator performance are driving revenue and supporting steady earnings growth across the global hospital portfolio. International expansion and access to affordable capital are enhancing portfolio diversification and enabling sustainable, long-term revenue streams.
View narrative
US$4.86
FV
16.6% undervalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
106
users have followed this narrative
3 days ago
author updated this narrative
Amneal Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Global Health Trends And Pipeline Launches Will Fuel Future Potential
Key Takeaways Diversification into branded, complex products and biosimilars, along with global expansion and partnerships, positions the company for continued revenue and profit growth. Investments in manufacturing, supply chain optimization, and improved financial flexibility strengthen operational resilience and support margin improvement amid shifting healthcare dynamics.
View narrative
US$12.00
FV
21.3% undervalued
intrinsic discount
7.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Mercury Systems
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
US And European Defense Trends Will Drive Transformation
Key Takeaways Alignment with global defense modernization and digitization trends is driving higher-margin contracts, improved backlog quality, and greater revenue visibility. Operational enhancements and R&D investments support margin expansion and a shift toward a more predictable, higher-value earnings model.
View narrative
US$65.43
FV
1.9% overvalued
intrinsic discount
6.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Alignment Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Digital Health And Automation Will Support Medicare Expansion
Key Takeaways Proprietary technology and automation reduce costs, boost scalability, and support sustained margin and earnings growth alongside durable clinical and operational advantages. Demographic trends and geographic expansion fuel long-term membership and revenue growth, while industry-leading performance strengthens competitive positioning and future profitability.
View narrative
US$18.90
FV
20.4% undervalued
intrinsic discount
26.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
PAR Technology
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Unified Cloud Platform Will Open New Global Markets
Key Takeaways Accelerating adoption of bundled, cloud-native solutions and cross-selling is driving higher gross margins, strong recurring revenue growth, and improved profitability outlook. Delayed but secured major deals and late-stage enterprise negotiations provide high visibility for future revenue and operational upside through international expansion and SaaS focus.
View narrative
US$81.75
FV
36.5% undervalued
intrinsic discount
13.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
LifeStance Health Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
US Mental Health Demand And AI Will Expand Care Access
Key Takeaways Rising demand, favorable insurance trends, and policy support are set to drive predictable growth and revenue for LifeStance. Technology investment, clinician productivity initiatives, and expansion plans are positioned to scale profits and boost long-term margins.
View narrative
US$8.43
FV
35.5% undervalued
intrinsic discount
14.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
Ambarella
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Leveraging Edge AI Processing With DeepSeek-R1 Will Unlock New Applications
Key Takeaways Ambarella's focus on edge AI, innovative SoCs, and automotive market expansion is driving potential revenue and earnings growth. Commitment to advanced technologies and efficiency improvements positions Ambarella for margin expansion and future growth.
View narrative
US$77.72
FV
13.8% undervalued
intrinsic discount
15.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
3 days ago
author updated this narrative
Rumble
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
International Partnerships And Cloud Investments Will Expand Global Reach
Key Takeaways New product launches and partnerships diversify revenue streams, expand monetization, and reduce reliance on a niche user base. International expansion and investment in AI infrastructure position the company for user growth, higher margins, and long-term earnings strength.
View narrative
US$14.50
FV
45.5% undervalued
intrinsic discount
23.13%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
3 days ago
author updated this narrative
Ultragenyx Pharmaceutical
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Advancements In Genomics And Rare Therapies Will Expand Prospects
Key Takeaways Expansion of the rare disease market and favorable regulatory environment are driving strong revenue growth and pricing power for Ultragenyx's therapies. Advancing late-stage pipeline, successful product launches, and gene therapy innovation position the company for diversified growth and improved profitability.
View narrative
US$86.05
FV
65.5% undervalued
intrinsic discount
31.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies